STTKShattuck Labs, Inc.

$284M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-23.7% YoY

Gross Profit

-$8M-355.4% margin

Operating Income

-$12M-547.3% margin

Net Income

-$12M-520.4% margin

EPS (Diluted)

$-0.28

QoQ Revenue Growth

+69.2%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$14M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$337M

Total Liabilities

$38M

Stockholders' Equity

$299M

Cash & Equivalents

$85M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$3M	-23.7%
Gross Profit	-$8M	-$5M	-56.3%
Operating Income	-$12M	-$7M	-83.7%
Net Income	-$12M	-$7M	-80.2%

STTK Q1 2021 Earnings — Shattuck Labs, Inc. Revenue & Financial Results | Market Cap Arena